Love the podcast? Send us a text!

What if your cancer treatment was designed just for you?

In this episode of Breast Cancer Conversations, host Dr. Laura Carfang sits down with Jim Foote, CEO and co-founder of First Ascent Biomedical, to explore how AI-powered functional precision medicine is transforming cancer care.

Instead of relying on one-size-fits-all treatment plans, this breakthrough approach tests your actual tumor cells against hundreds of FDA-approved drugs—revealing which therapies truly work for you and which don’t.

🧬 You’ll learn:

• How functional precision medicine differs from genetic testing
• Why AI and lab automation are revolutionizing oncology
• Real-life patient stories of hope and survival
• How this technology cuts costs and reduces toxicity
• Why personalization could become the new standard of care

🎧 Tune in to hear how technology, compassion, and science are coming together to rewrite the future of cancer treatment.

👉 Watch. Learn. Share. Because the future of oncology is personal.

🔗 Resources & Links:

• SurvivingBreastCancer.org
  
  
• First Ascent Biomedical
  
  
• Follow us on Instagram: @SurvivingBreastCancerOrg
  
  
• Listen on Apple Podcasts, Spotify, or wherever you get your podcasts

💬 Join the conversation:
What are your thoughts on personalized medicine? Leave a comment below and tell us how AI could change your cancer journey.

Support the show

Listener Feedback

If this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.

You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.

Messages are completely anonymous.

If you would like us to follow up directly, please include your email address in your message so we can respond.

Latest News: 

• Join our Mailing List - New content drops every Monday! 
• Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! 
• Become a Breast Cancer Conversations+ Member! Sign Up Now. 
• Enjoying our content? Please consider supporting our work.